nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—UGT1A1—lung cancer	0.11	0.279	CbGaD
Diclofenac—CXCL8—lung cancer	0.104	0.263	CbGaD
Diclofenac—CYP2E1—lung cancer	0.0491	0.125	CbGaD
Diclofenac—CYP1A1—lung cancer	0.0484	0.123	CbGaD
Diclofenac—PTGS2—lung cancer	0.0303	0.0768	CbGaD
Diclofenac—ALB—lung cancer	0.027	0.0684	CbGaD
Diclofenac—ABCB1—lung cancer	0.0257	0.0653	CbGaD
Diclofenac—SLCO1C1—Methotrexate—lung cancer	0.0165	0.0467	CbGbCtD
Diclofenac—UGT1A1—Erlotinib—lung cancer	0.0162	0.0459	CbGbCtD
Diclofenac—UGT1A1—Irinotecan—lung cancer	0.0147	0.0415	CbGbCtD
Diclofenac—CYP1A1—Gefitinib—lung cancer	0.0139	0.0394	CbGbCtD
Diclofenac—ABCC1—Paclitaxel—lung cancer	0.0122	0.0346	CbGbCtD
Diclofenac—ABCC1—Irinotecan—lung cancer	0.0121	0.0341	CbGbCtD
Diclofenac—UGT1A1—Etoposide—lung cancer	0.0117	0.0332	CbGbCtD
Diclofenac—ABCC1—Vinblastine—lung cancer	0.0107	0.0303	CbGbCtD
Diclofenac—ALB—Gefitinib—lung cancer	0.0104	0.0295	CbGbCtD
Diclofenac—ABCC1—Etoposide—lung cancer	0.00965	0.0273	CbGbCtD
Diclofenac—ABCC1—Docetaxel—lung cancer	0.00883	0.025	CbGbCtD
Diclofenac—SLC22A11—Methotrexate—lung cancer	0.00853	0.0241	CbGbCtD
Diclofenac—CYP1A1—Erlotinib—lung cancer	0.00824	0.0233	CbGbCtD
Diclofenac—ABCC4—Methotrexate—lung cancer	0.00794	0.0224	CbGbCtD
Diclofenac—PTGS2—Cisplatin—lung cancer	0.00719	0.0203	CbGbCtD
Diclofenac—PTGS2—Etoposide—lung cancer	0.00706	0.02	CbGbCtD
Diclofenac—CYP2C19—Gefitinib—lung cancer	0.00675	0.0191	CbGbCtD
Diclofenac—ABCC1—Doxorubicin—lung cancer	0.00658	0.0186	CbGbCtD
Diclofenac—CYP2C19—Teniposide—lung cancer	0.00654	0.0185	CbGbCtD
Diclofenac—ABCC1—Methotrexate—lung cancer	0.00638	0.018	CbGbCtD
Diclofenac—ALB—Erlotinib—lung cancer	0.00616	0.0174	CbGbCtD
Diclofenac—PTGS1—Etoposide—lung cancer	0.00596	0.0169	CbGbCtD
Diclofenac—ABCB1—Topotecan—lung cancer	0.00595	0.0168	CbGbCtD
Diclofenac—CYP2B6—Irinotecan—lung cancer	0.00567	0.016	CbGbCtD
Diclofenac—CYP2C9—Gefitinib—lung cancer	0.00561	0.0159	CbGbCtD
Diclofenac—ALB—Irinotecan—lung cancer	0.00556	0.0157	CbGbCtD
Diclofenac—ABCB1—Gefitinib—lung cancer	0.00545	0.0154	CbGbCtD
Diclofenac—CYP2C9—Teniposide—lung cancer	0.00544	0.0154	CbGbCtD
Diclofenac—SLC22A8—Methotrexate—lung cancer	0.00496	0.014	CbGbCtD
Diclofenac—CYP2C8—Erlotinib—lung cancer	0.00476	0.0135	CbGbCtD
Diclofenac—CYP2B6—Cisplatin—lung cancer	0.00462	0.0131	CbGbCtD
Diclofenac—CYP2E1—Etoposide—lung cancer	0.00461	0.013	CbGbCtD
Diclofenac—CYP2C8—Paclitaxel—lung cancer	0.00435	0.0123	CbGbCtD
Diclofenac—ABCB1—Vinorelbine—lung cancer	0.00419	0.0119	CbGbCtD
Diclofenac—CYP1A2—Erlotinib—lung cancer	0.00368	0.0104	CbGbCtD
Diclofenac—CYP3A4—Topotecan—lung cancer	0.00357	0.0101	CbGbCtD
Diclofenac—SLC22A6—Methotrexate—lung cancer	0.00345	0.00977	CbGbCtD
Diclofenac—CYP2C8—Etoposide—lung cancer	0.00344	0.00973	CbGbCtD
Diclofenac—ABCB1—Crizotinib—lung cancer	0.00334	0.00944	CbGbCtD
Diclofenac—CYP3A4—Gefitinib—lung cancer	0.00326	0.00923	CbGbCtD
Diclofenac—ABCB1—Gemcitabine—lung cancer	0.00326	0.00923	CbGbCtD
Diclofenac—ABCB1—Erlotinib—lung cancer	0.00322	0.00911	CbGbCtD
Diclofenac—CYP3A4—Teniposide—lung cancer	0.00316	0.00895	CbGbCtD
Diclofenac—CYP2B6—Doxorubicin—lung cancer	0.0031	0.00877	CbGbCtD
Diclofenac—CYP2C9—Paclitaxel—lung cancer	0.00304	0.00859	CbGbCtD
Diclofenac—ABCB1—Paclitaxel—lung cancer	0.00295	0.00834	CbGbCtD
Diclofenac—ALB—Methotrexate—lung cancer	0.00294	0.00832	CbGbCtD
Diclofenac—ABCB1—Irinotecan—lung cancer	0.00291	0.00823	CbGbCtD
Diclofenac—CYP1A2—Etoposide—lung cancer	0.00266	0.00753	CbGbCtD
Diclofenac—ABCB1—Vinblastine—lung cancer	0.00259	0.00731	CbGbCtD
Diclofenac—CYP3A4—Vinorelbine—lung cancer	0.00251	0.00711	CbGbCtD
Diclofenac—CYP2C9—Cisplatin—lung cancer	0.00244	0.00691	CbGbCtD
Diclofenac—ABCB1—Cisplatin—lung cancer	0.00237	0.00671	CbGbCtD
Diclofenac—ABCB1—Etoposide—lung cancer	0.00233	0.00659	CbGbCtD
Diclofenac—ABCB1—Docetaxel—lung cancer	0.00213	0.00603	CbGbCtD
Diclofenac—CYP3A4—Crizotinib—lung cancer	0.002	0.00566	CbGbCtD
Diclofenac—CYP3A4—Erlotinib—lung cancer	0.00193	0.00546	CbGbCtD
Diclofenac—CYP3A4—Paclitaxel—lung cancer	0.00177	0.005	CbGbCtD
Diclofenac—CYP3A4—Irinotecan—lung cancer	0.00174	0.00493	CbGbCtD
Diclofenac—ABCB1—Doxorubicin—lung cancer	0.00159	0.00449	CbGbCtD
Diclofenac—CYP3A4—Vinblastine—lung cancer	0.00155	0.00438	CbGbCtD
Diclofenac—ABCB1—Methotrexate—lung cancer	0.00154	0.00435	CbGbCtD
Diclofenac—CXCR1—bone marrow—lung cancer	0.0014	0.0568	CbGeAlD
Diclofenac—CYP3A4—Etoposide—lung cancer	0.0014	0.00395	CbGbCtD
Diclofenac—CYP3A4—Docetaxel—lung cancer	0.00128	0.00361	CbGbCtD
Diclofenac—CXCR1—lung—lung cancer	0.00127	0.0514	CbGeAlD
Diclofenac—Mefenamic acid—AKR1C1—lung cancer	0.00112	0.494	CrCbGaD
Diclofenac—CYP3A4—Doxorubicin—lung cancer	0.000952	0.00269	CbGbCtD
Diclofenac—CXCR1—lymph node—lung cancer	0.000867	0.0352	CbGeAlD
Diclofenac—PLA2G2A—respiratory system—lung cancer	0.000856	0.0347	CbGeAlD
Diclofenac—PLA2G2A—epithelium—lung cancer	0.000715	0.029	CbGeAlD
Diclofenac—PLA2G2A—bronchus—lung cancer	0.000704	0.0286	CbGeAlD
Diclofenac—CXCL8—bronchus—lung cancer	0.000697	0.0283	CbGeAlD
Diclofenac—TTR—respiratory system—lung cancer	0.000646	0.0262	CbGeAlD
Diclofenac—CYP2C18—bronchus—lung cancer	0.000643	0.0261	CbGeAlD
Diclofenac—PLA2G2A—trachea—lung cancer	0.000632	0.0257	CbGeAlD
Diclofenac—CXCL8—trachea—lung cancer	0.000626	0.0254	CbGeAlD
Diclofenac—ALB—mammary gland—lung cancer	0.000619	0.0251	CbGeAlD
Diclofenac—KCNQ3—lung—lung cancer	0.000599	0.0243	CbGeAlD
Diclofenac—PLA2G2A—cardiac atrium—lung cancer	0.000594	0.0241	CbGeAlD
Diclofenac—ALOX5—respiratory system—lung cancer	0.000585	0.0237	CbGeAlD
Diclofenac—ASIC1—lymph node—lung cancer	0.000516	0.0209	CbGeAlD
Diclofenac—CXCL8—bone marrow—lung cancer	0.000496	0.0201	CbGeAlD
Diclofenac—ALOX5—bronchus—lung cancer	0.000482	0.0195	CbGeAlD
Diclofenac—PLA2G2A—lung—lung cancer	0.000454	0.0184	CbGeAlD
Diclofenac—CXCL8—lung—lung cancer	0.00045	0.0182	CbGeAlD
Diclofenac—CYP2C8—mammary gland—lung cancer	0.000435	0.0176	CbGeAlD
Diclofenac—CYP2C9—mammary gland—lung cancer	0.000386	0.0157	CbGeAlD
Diclofenac—TTR—bone marrow—lung cancer	0.000379	0.0154	CbGeAlD
Diclofenac—ALOX5—bone marrow—lung cancer	0.000343	0.0139	CbGeAlD
Diclofenac—TTR—lung—lung cancer	0.000343	0.0139	CbGeAlD
Diclofenac—ABCC4—bronchus—lung cancer	0.000328	0.0133	CbGeAlD
Diclofenac—ALOX5—lung—lung cancer	0.000311	0.0126	CbGeAlD
Diclofenac—PLA2G2A—lymph node—lung cancer	0.000311	0.0126	CbGeAlD
Diclofenac—CXCL8—lymph node—lung cancer	0.000308	0.0125	CbGeAlD
Diclofenac—ABCC1—bronchus—lung cancer	0.00028	0.0114	CbGeAlD
Diclofenac—CYP1A2—respiratory system—lung cancer	0.000271	0.011	CbGeAlD
Diclofenac—CYP1A1—respiratory system—lung cancer	0.000267	0.0108	CbGeAlD
Diclofenac—SLCO1C1—lymph node—lung cancer	0.000262	0.0106	CbGeAlD
Diclofenac—CYP2B6—respiratory system—lung cancer	0.00026	0.0105	CbGeAlD
Diclofenac—ABCC1—trachea—lung cancer	0.000251	0.0102	CbGeAlD
Diclofenac—CYP2E1—respiratory system—lung cancer	0.000244	0.00989	CbGeAlD
Diclofenac—ABCC1—cardiac atrium—lung cancer	0.000236	0.00958	CbGeAlD
Diclofenac—PTGS1—respiratory system—lung cancer	0.000235	0.00953	CbGeAlD
Diclofenac—ABCC4—bone marrow—lung cancer	0.000234	0.00949	CbGeAlD
Diclofenac—PTGS2—respiratory system—lung cancer	0.000225	0.00911	CbGeAlD
Diclofenac—CYP1A1—epithelium—lung cancer	0.000223	0.00907	CbGeAlD
Diclofenac—Bromfenac—PTGS2—lung cancer	0.000222	0.0977	CrCbGaD
Diclofenac—CYP1A1—bronchus—lung cancer	0.00022	0.00893	CbGeAlD
Diclofenac—CYP2B6—bronchus—lung cancer	0.000214	0.00868	CbGeAlD
Diclofenac—ALOX5—lymph node—lung cancer	0.000213	0.00862	CbGeAlD
Diclofenac—ABCC4—lung—lung cancer	0.000212	0.0086	CbGeAlD
Diclofenac—CYP1A1—trachea—lung cancer	0.000198	0.00802	CbGeAlD
Diclofenac—PTGS1—epithelium—lung cancer	0.000196	0.00797	CbGeAlD
Diclofenac—Clonidine—CYP1A1—lung cancer	0.000195	0.0856	CrCbGaD
Diclofenac—Lumiracoxib—PTGS2—lung cancer	0.000189	0.083	CrCbGaD
Diclofenac—PTGS2—epithelium—lung cancer	0.000188	0.00761	CbGeAlD
Diclofenac—CYP1A1—cardiac atrium—lung cancer	0.000186	0.00753	CbGeAlD
Diclofenac—PTGS2—bronchus—lung cancer	0.000185	0.0075	CbGeAlD
Diclofenac—ABCC1—lung—lung cancer	0.000181	0.00733	CbGeAlD
Diclofenac—Nepafenac—PTGS2—lung cancer	0.00018	0.079	CrCbGaD
Diclofenac—PTGS1—trachea—lung cancer	0.000174	0.00704	CbGeAlD
Diclofenac—PTGS2—trachea—lung cancer	0.000166	0.00673	CbGeAlD
Diclofenac—PTGS1—cardiac atrium—lung cancer	0.000163	0.00662	CbGeAlD
Diclofenac—ALB—lymph node—lung cancer	0.00015	0.00607	CbGeAlD
Diclofenac—Meclofenamic acid—PTGS2—lung cancer	0.000147	0.0647	CrCbGaD
Diclofenac—ABCC4—lymph node—lung cancer	0.000145	0.00588	CbGeAlD
Diclofenac—CYP1A2—lung—lung cancer	0.000144	0.00584	CbGeAlD
Diclofenac—CYP1A1—lung—lung cancer	0.000142	0.00576	CbGeAlD
Diclofenac—ABCB1—respiratory system—lung cancer	0.000139	0.00564	CbGeAlD
Diclofenac—CYP2B6—lung—lung cancer	0.000138	0.0056	CbGeAlD
Diclofenac—PTGS2—bone marrow—lung cancer	0.000132	0.00534	CbGeAlD
Diclofenac—CYP2E1—lung—lung cancer	0.00013	0.00525	CbGeAlD
Diclofenac—PTGS1—lung—lung cancer	0.000125	0.00506	CbGeAlD
Diclofenac—ABCC1—lymph node—lung cancer	0.000124	0.00501	CbGeAlD
Diclofenac—PTGS2—lung—lung cancer	0.000119	0.00484	CbGeAlD
Diclofenac—ABCB1—epithelium—lung cancer	0.000116	0.00471	CbGeAlD
Diclofenac—Mefenamic acid—PTGS2—lung cancer	0.000115	0.0503	CrCbGaD
Diclofenac—Clonidine—ABCB1—lung cancer	0.000104	0.0455	CrCbGaD
Diclofenac—ABCB1—trachea—lung cancer	0.000103	0.00416	CbGeAlD
Diclofenac—CYP1A1—lymph node—lung cancer	9.71e-05	0.00394	CbGeAlD
Diclofenac—PTGS1—lymph node—lung cancer	8.53e-05	0.00346	CbGeAlD
Diclofenac—PTGS2—lymph node—lung cancer	8.16e-05	0.00331	CbGeAlD
Diclofenac—ABCB1—bone marrow—lung cancer	8.14e-05	0.0033	CbGeAlD
Diclofenac—ABCB1—lung—lung cancer	7.38e-05	0.00299	CbGeAlD
Diclofenac—ABCB1—lymph node—lung cancer	5.04e-05	0.00205	CbGeAlD
Diclofenac—Hyperglycaemia—Doxorubicin—lung cancer	2.56e-05	0.000198	CcSEcCtD
Diclofenac—Diarrhoea—Irinotecan—lung cancer	2.56e-05	0.000198	CcSEcCtD
Diclofenac—Pneumonia—Doxorubicin—lung cancer	2.54e-05	0.000197	CcSEcCtD
Diclofenac—Gastrointestinal pain—Etoposide—lung cancer	2.54e-05	0.000197	CcSEcCtD
Diclofenac—Shock—Docetaxel—lung cancer	2.54e-05	0.000197	CcSEcCtD
Diclofenac—Nervous system disorder—Docetaxel—lung cancer	2.53e-05	0.000196	CcSEcCtD
Diclofenac—Thrombocytopenia—Docetaxel—lung cancer	2.53e-05	0.000196	CcSEcCtD
Diclofenac—Drowsiness—Doxorubicin—lung cancer	2.53e-05	0.000196	CcSEcCtD
Diclofenac—Infestation NOS—Doxorubicin—lung cancer	2.53e-05	0.000196	CcSEcCtD
Diclofenac—Infestation—Doxorubicin—lung cancer	2.53e-05	0.000196	CcSEcCtD
Diclofenac—Visual impairment—Methotrexate—lung cancer	2.53e-05	0.000196	CcSEcCtD
Diclofenac—Tachycardia—Docetaxel—lung cancer	2.52e-05	0.000195	CcSEcCtD
Diclofenac—Feeling abnormal—Paclitaxel—lung cancer	2.51e-05	0.000195	CcSEcCtD
Diclofenac—Skin disorder—Docetaxel—lung cancer	2.51e-05	0.000194	CcSEcCtD
Diclofenac—Stevens-Johnson syndrome—Doxorubicin—lung cancer	2.51e-05	0.000194	CcSEcCtD
Diclofenac—Hypersensitivity—Cisplatin—lung cancer	2.5e-05	0.000194	CcSEcCtD
Diclofenac—Gastrointestinal pain—Paclitaxel—lung cancer	2.49e-05	0.000193	CcSEcCtD
Diclofenac—Diarrhoea—Gemcitabine—lung cancer	2.49e-05	0.000193	CcSEcCtD
Diclofenac—Renal failure—Doxorubicin—lung cancer	2.49e-05	0.000192	CcSEcCtD
Diclofenac—Erythema multiforme—Methotrexate—lung cancer	2.48e-05	0.000192	CcSEcCtD
Diclofenac—Neuropathy peripheral—Doxorubicin—lung cancer	2.48e-05	0.000192	CcSEcCtD
Diclofenac—Dizziness—Irinotecan—lung cancer	2.47e-05	0.000191	CcSEcCtD
Diclofenac—Urticaria—Etoposide—lung cancer	2.47e-05	0.000191	CcSEcCtD
Diclofenac—Stomatitis—Doxorubicin—lung cancer	2.47e-05	0.000191	CcSEcCtD
Diclofenac—Jaundice—Doxorubicin—lung cancer	2.47e-05	0.000191	CcSEcCtD
Diclofenac—Anorexia—Docetaxel—lung cancer	2.46e-05	0.000191	CcSEcCtD
Diclofenac—Abdominal pain—Etoposide—lung cancer	2.46e-05	0.00019	CcSEcCtD
Diclofenac—Body temperature increased—Etoposide—lung cancer	2.46e-05	0.00019	CcSEcCtD
Diclofenac—Conjunctivitis—Doxorubicin—lung cancer	2.46e-05	0.00019	CcSEcCtD
Diclofenac—Urinary tract infection—Doxorubicin—lung cancer	2.46e-05	0.00019	CcSEcCtD
Diclofenac—Eye disorder—Methotrexate—lung cancer	2.45e-05	0.00019	CcSEcCtD
Diclofenac—Tinnitus—Methotrexate—lung cancer	2.44e-05	0.000189	CcSEcCtD
Diclofenac—Asthenia—Cisplatin—lung cancer	2.44e-05	0.000189	CcSEcCtD
Diclofenac—Cardiac disorder—Methotrexate—lung cancer	2.43e-05	0.000188	CcSEcCtD
Diclofenac—Sweating—Doxorubicin—lung cancer	2.42e-05	0.000188	CcSEcCtD
Diclofenac—Urticaria—Paclitaxel—lung cancer	2.42e-05	0.000188	CcSEcCtD
Diclofenac—Hypotension—Docetaxel—lung cancer	2.41e-05	0.000187	CcSEcCtD
Diclofenac—Haematuria—Doxorubicin—lung cancer	2.41e-05	0.000187	CcSEcCtD
Diclofenac—Abdominal pain—Paclitaxel—lung cancer	2.41e-05	0.000187	CcSEcCtD
Diclofenac—Body temperature increased—Paclitaxel—lung cancer	2.41e-05	0.000187	CcSEcCtD
Diclofenac—Hepatobiliary disease—Doxorubicin—lung cancer	2.39e-05	0.000185	CcSEcCtD
Diclofenac—Epistaxis—Doxorubicin—lung cancer	2.39e-05	0.000185	CcSEcCtD
Diclofenac—Angiopathy—Methotrexate—lung cancer	2.38e-05	0.000184	CcSEcCtD
Diclofenac—Vomiting—Irinotecan—lung cancer	2.38e-05	0.000184	CcSEcCtD
Diclofenac—Sinusitis—Doxorubicin—lung cancer	2.37e-05	0.000184	CcSEcCtD
Diclofenac—Immune system disorder—Methotrexate—lung cancer	2.37e-05	0.000183	CcSEcCtD
Diclofenac—Mediastinal disorder—Methotrexate—lung cancer	2.36e-05	0.000183	CcSEcCtD
Diclofenac—Agranulocytosis—Doxorubicin—lung cancer	2.36e-05	0.000183	CcSEcCtD
Diclofenac—Rash—Irinotecan—lung cancer	2.36e-05	0.000183	CcSEcCtD
Diclofenac—Dermatitis—Irinotecan—lung cancer	2.36e-05	0.000182	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Docetaxel—lung cancer	2.35e-05	0.000182	CcSEcCtD
Diclofenac—Chills—Methotrexate—lung cancer	2.35e-05	0.000182	CcSEcCtD
Diclofenac—Headache—Irinotecan—lung cancer	2.34e-05	0.000181	CcSEcCtD
Diclofenac—Insomnia—Docetaxel—lung cancer	2.34e-05	0.000181	CcSEcCtD
Diclofenac—Diarrhoea—Cisplatin—lung cancer	2.32e-05	0.00018	CcSEcCtD
Diclofenac—Paraesthesia—Docetaxel—lung cancer	2.32e-05	0.00018	CcSEcCtD
Diclofenac—Alopecia—Methotrexate—lung cancer	2.32e-05	0.000179	CcSEcCtD
Diclofenac—Vomiting—Gemcitabine—lung cancer	2.32e-05	0.000179	CcSEcCtD
Diclofenac—Bradycardia—Doxorubicin—lung cancer	2.31e-05	0.000179	CcSEcCtD
Diclofenac—Dyspnoea—Docetaxel—lung cancer	2.3e-05	0.000178	CcSEcCtD
Diclofenac—Somnolence—Docetaxel—lung cancer	2.3e-05	0.000178	CcSEcCtD
Diclofenac—Mental disorder—Methotrexate—lung cancer	2.3e-05	0.000178	CcSEcCtD
Diclofenac—Rash—Gemcitabine—lung cancer	2.3e-05	0.000178	CcSEcCtD
Diclofenac—Dermatitis—Gemcitabine—lung cancer	2.29e-05	0.000178	CcSEcCtD
Diclofenac—Hypersensitivity—Etoposide—lung cancer	2.29e-05	0.000177	CcSEcCtD
Diclofenac—Malnutrition—Methotrexate—lung cancer	2.28e-05	0.000177	CcSEcCtD
Diclofenac—Erythema—Methotrexate—lung cancer	2.28e-05	0.000177	CcSEcCtD
Diclofenac—Haemoglobin—Doxorubicin—lung cancer	2.28e-05	0.000177	CcSEcCtD
Diclofenac—Headache—Gemcitabine—lung cancer	2.28e-05	0.000177	CcSEcCtD
Diclofenac—Rhinitis—Doxorubicin—lung cancer	2.28e-05	0.000176	CcSEcCtD
Diclofenac—Dyspepsia—Docetaxel—lung cancer	2.27e-05	0.000176	CcSEcCtD
Diclofenac—Haemorrhage—Doxorubicin—lung cancer	2.27e-05	0.000176	CcSEcCtD
Diclofenac—Hepatitis—Doxorubicin—lung cancer	2.27e-05	0.000176	CcSEcCtD
Diclofenac—Hypoaesthesia—Doxorubicin—lung cancer	2.26e-05	0.000175	CcSEcCtD
Diclofenac—Pharyngitis—Doxorubicin—lung cancer	2.25e-05	0.000174	CcSEcCtD
Diclofenac—Decreased appetite—Docetaxel—lung cancer	2.25e-05	0.000174	CcSEcCtD
Diclofenac—Hypersensitivity—Paclitaxel—lung cancer	2.25e-05	0.000174	CcSEcCtD
Diclofenac—Urinary tract disorder—Doxorubicin—lung cancer	2.24e-05	0.000174	CcSEcCtD
Diclofenac—Oedema peripheral—Doxorubicin—lung cancer	2.24e-05	0.000173	CcSEcCtD
Diclofenac—Dysgeusia—Methotrexate—lung cancer	2.24e-05	0.000173	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Docetaxel—lung cancer	2.23e-05	0.000173	CcSEcCtD
Diclofenac—Asthenia—Etoposide—lung cancer	2.23e-05	0.000173	CcSEcCtD
Diclofenac—Fatigue—Docetaxel—lung cancer	2.23e-05	0.000173	CcSEcCtD
Diclofenac—Urethral disorder—Doxorubicin—lung cancer	2.23e-05	0.000172	CcSEcCtD
Diclofenac—Nausea—Irinotecan—lung cancer	2.22e-05	0.000172	CcSEcCtD
Diclofenac—Pain—Docetaxel—lung cancer	2.21e-05	0.000171	CcSEcCtD
Diclofenac—Constipation—Docetaxel—lung cancer	2.21e-05	0.000171	CcSEcCtD
Diclofenac—Back pain—Methotrexate—lung cancer	2.21e-05	0.000171	CcSEcCtD
Diclofenac—Pruritus—Etoposide—lung cancer	2.2e-05	0.00017	CcSEcCtD
Diclofenac—Visual impairment—Doxorubicin—lung cancer	2.19e-05	0.000169	CcSEcCtD
Diclofenac—Asthenia—Paclitaxel—lung cancer	2.19e-05	0.000169	CcSEcCtD
Diclofenac—Nausea—Gemcitabine—lung cancer	2.16e-05	0.000167	CcSEcCtD
Diclofenac—Vomiting—Cisplatin—lung cancer	2.16e-05	0.000167	CcSEcCtD
Diclofenac—Pruritus—Paclitaxel—lung cancer	2.16e-05	0.000167	CcSEcCtD
Diclofenac—Vision blurred—Methotrexate—lung cancer	2.15e-05	0.000167	CcSEcCtD
Diclofenac—Erythema multiforme—Doxorubicin—lung cancer	2.15e-05	0.000166	CcSEcCtD
Diclofenac—Rash—Cisplatin—lung cancer	2.14e-05	0.000166	CcSEcCtD
Diclofenac—Dermatitis—Cisplatin—lung cancer	2.14e-05	0.000166	CcSEcCtD
Diclofenac—Feeling abnormal—Docetaxel—lung cancer	2.13e-05	0.000165	CcSEcCtD
Diclofenac—Diarrhoea—Etoposide—lung cancer	2.13e-05	0.000165	CcSEcCtD
Diclofenac—Eye disorder—Doxorubicin—lung cancer	2.12e-05	0.000164	CcSEcCtD
Diclofenac—Ill-defined disorder—Methotrexate—lung cancer	2.12e-05	0.000164	CcSEcCtD
Diclofenac—Tinnitus—Doxorubicin—lung cancer	2.12e-05	0.000164	CcSEcCtD
Diclofenac—Gastrointestinal pain—Docetaxel—lung cancer	2.11e-05	0.000164	CcSEcCtD
Diclofenac—Anaemia—Methotrexate—lung cancer	2.11e-05	0.000163	CcSEcCtD
Diclofenac—Flushing—Doxorubicin—lung cancer	2.11e-05	0.000163	CcSEcCtD
Diclofenac—Cardiac disorder—Doxorubicin—lung cancer	2.11e-05	0.000163	CcSEcCtD
Diclofenac—Diarrhoea—Paclitaxel—lung cancer	2.09e-05	0.000162	CcSEcCtD
Diclofenac—Angiopathy—Doxorubicin—lung cancer	2.06e-05	0.000159	CcSEcCtD
Diclofenac—Malaise—Methotrexate—lung cancer	2.06e-05	0.000159	CcSEcCtD
Diclofenac—Dizziness—Etoposide—lung cancer	2.06e-05	0.000159	CcSEcCtD
Diclofenac—Immune system disorder—Doxorubicin—lung cancer	2.05e-05	0.000159	CcSEcCtD
Diclofenac—Vertigo—Methotrexate—lung cancer	2.05e-05	0.000159	CcSEcCtD
Diclofenac—Mediastinal disorder—Doxorubicin—lung cancer	2.05e-05	0.000158	CcSEcCtD
Diclofenac—Abdominal pain—Docetaxel—lung cancer	2.04e-05	0.000158	CcSEcCtD
Diclofenac—Body temperature increased—Docetaxel—lung cancer	2.04e-05	0.000158	CcSEcCtD
Diclofenac—Leukopenia—Methotrexate—lung cancer	2.04e-05	0.000158	CcSEcCtD
Diclofenac—Chills—Doxorubicin—lung cancer	2.04e-05	0.000158	CcSEcCtD
Diclofenac—Arrhythmia—Doxorubicin—lung cancer	2.03e-05	0.000157	CcSEcCtD
Diclofenac—Dizziness—Paclitaxel—lung cancer	2.02e-05	0.000156	CcSEcCtD
Diclofenac—Nausea—Cisplatin—lung cancer	2.02e-05	0.000156	CcSEcCtD
Diclofenac—Alopecia—Doxorubicin—lung cancer	2.01e-05	0.000155	CcSEcCtD
Diclofenac—Cough—Methotrexate—lung cancer	1.99e-05	0.000154	CcSEcCtD
Diclofenac—Mental disorder—Doxorubicin—lung cancer	1.99e-05	0.000154	CcSEcCtD
Diclofenac—Convulsion—Methotrexate—lung cancer	1.98e-05	0.000153	CcSEcCtD
Diclofenac—Vomiting—Etoposide—lung cancer	1.98e-05	0.000153	CcSEcCtD
Diclofenac—Erythema—Doxorubicin—lung cancer	1.98e-05	0.000153	CcSEcCtD
Diclofenac—Malnutrition—Doxorubicin—lung cancer	1.98e-05	0.000153	CcSEcCtD
Diclofenac—Rash—Etoposide—lung cancer	1.96e-05	0.000152	CcSEcCtD
Diclofenac—Dermatitis—Etoposide—lung cancer	1.96e-05	0.000152	CcSEcCtD
Diclofenac—Headache—Etoposide—lung cancer	1.95e-05	0.000151	CcSEcCtD
Diclofenac—Flatulence—Doxorubicin—lung cancer	1.95e-05	0.000151	CcSEcCtD
Diclofenac—Arthralgia—Methotrexate—lung cancer	1.94e-05	0.00015	CcSEcCtD
Diclofenac—Chest pain—Methotrexate—lung cancer	1.94e-05	0.00015	CcSEcCtD
Diclofenac—Myalgia—Methotrexate—lung cancer	1.94e-05	0.00015	CcSEcCtD
Diclofenac—Tension—Doxorubicin—lung cancer	1.94e-05	0.00015	CcSEcCtD
Diclofenac—Vomiting—Paclitaxel—lung cancer	1.94e-05	0.00015	CcSEcCtD
Diclofenac—Dysgeusia—Doxorubicin—lung cancer	1.94e-05	0.00015	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	1.93e-05	0.000149	CcSEcCtD
Diclofenac—Rash—Paclitaxel—lung cancer	1.92e-05	0.000149	CcSEcCtD
Diclofenac—Dermatitis—Paclitaxel—lung cancer	1.92e-05	0.000149	CcSEcCtD
Diclofenac—Discomfort—Methotrexate—lung cancer	1.92e-05	0.000149	CcSEcCtD
Diclofenac—Nervousness—Doxorubicin—lung cancer	1.92e-05	0.000149	CcSEcCtD
Diclofenac—Back pain—Doxorubicin—lung cancer	1.91e-05	0.000148	CcSEcCtD
Diclofenac—Headache—Paclitaxel—lung cancer	1.91e-05	0.000148	CcSEcCtD
Diclofenac—Hypersensitivity—Docetaxel—lung cancer	1.9e-05	0.000147	CcSEcCtD
Diclofenac—Muscle spasms—Doxorubicin—lung cancer	1.9e-05	0.000147	CcSEcCtD
Diclofenac—Confusional state—Methotrexate—lung cancer	1.88e-05	0.000145	CcSEcCtD
Diclofenac—Anaphylactic shock—Methotrexate—lung cancer	1.86e-05	0.000144	CcSEcCtD
Diclofenac—Vision blurred—Doxorubicin—lung cancer	1.86e-05	0.000144	CcSEcCtD
Diclofenac—Asthenia—Docetaxel—lung cancer	1.85e-05	0.000144	CcSEcCtD
Diclofenac—Infection—Methotrexate—lung cancer	1.85e-05	0.000143	CcSEcCtD
Diclofenac—Nausea—Etoposide—lung cancer	1.85e-05	0.000143	CcSEcCtD
Diclofenac—Ill-defined disorder—Doxorubicin—lung cancer	1.83e-05	0.000142	CcSEcCtD
Diclofenac—Pruritus—Docetaxel—lung cancer	1.83e-05	0.000142	CcSEcCtD
Diclofenac—Nervous system disorder—Methotrexate—lung cancer	1.83e-05	0.000141	CcSEcCtD
Diclofenac—Anaemia—Doxorubicin—lung cancer	1.83e-05	0.000141	CcSEcCtD
Diclofenac—Thrombocytopenia—Methotrexate—lung cancer	1.82e-05	0.000141	CcSEcCtD
Diclofenac—Agitation—Doxorubicin—lung cancer	1.82e-05	0.000141	CcSEcCtD
Diclofenac—Nausea—Paclitaxel—lung cancer	1.81e-05	0.00014	CcSEcCtD
Diclofenac—Skin disorder—Methotrexate—lung cancer	1.81e-05	0.00014	CcSEcCtD
Diclofenac—Hyperhidrosis—Methotrexate—lung cancer	1.8e-05	0.000139	CcSEcCtD
Diclofenac—Malaise—Doxorubicin—lung cancer	1.78e-05	0.000138	CcSEcCtD
Diclofenac—Vertigo—Doxorubicin—lung cancer	1.78e-05	0.000137	CcSEcCtD
Diclofenac—Anorexia—Methotrexate—lung cancer	1.78e-05	0.000137	CcSEcCtD
Diclofenac—Syncope—Doxorubicin—lung cancer	1.77e-05	0.000137	CcSEcCtD
Diclofenac—Leukopenia—Doxorubicin—lung cancer	1.77e-05	0.000137	CcSEcCtD
Diclofenac—Diarrhoea—Docetaxel—lung cancer	1.77e-05	0.000137	CcSEcCtD
Diclofenac—Palpitations—Doxorubicin—lung cancer	1.75e-05	0.000135	CcSEcCtD
Diclofenac—Hypotension—Methotrexate—lung cancer	1.74e-05	0.000135	CcSEcCtD
Diclofenac—Loss of consciousness—Doxorubicin—lung cancer	1.74e-05	0.000134	CcSEcCtD
Diclofenac—Cough—Doxorubicin—lung cancer	1.72e-05	0.000134	CcSEcCtD
Diclofenac—Convulsion—Doxorubicin—lung cancer	1.71e-05	0.000133	CcSEcCtD
Diclofenac—Dizziness—Docetaxel—lung cancer	1.71e-05	0.000132	CcSEcCtD
Diclofenac—Hypertension—Doxorubicin—lung cancer	1.71e-05	0.000132	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Methotrexate—lung cancer	1.7e-05	0.000131	CcSEcCtD
Diclofenac—Insomnia—Methotrexate—lung cancer	1.68e-05	0.00013	CcSEcCtD
Diclofenac—Myalgia—Doxorubicin—lung cancer	1.68e-05	0.00013	CcSEcCtD
Diclofenac—Chest pain—Doxorubicin—lung cancer	1.68e-05	0.00013	CcSEcCtD
Diclofenac—Arthralgia—Doxorubicin—lung cancer	1.68e-05	0.00013	CcSEcCtD
Diclofenac—Anxiety—Doxorubicin—lung cancer	1.68e-05	0.00013	CcSEcCtD
Diclofenac—Paraesthesia—Methotrexate—lung cancer	1.67e-05	0.00013	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	1.67e-05	0.000129	CcSEcCtD
Diclofenac—Discomfort—Doxorubicin—lung cancer	1.66e-05	0.000129	CcSEcCtD
Diclofenac—Dyspnoea—Methotrexate—lung cancer	1.66e-05	0.000129	CcSEcCtD
Diclofenac—Somnolence—Methotrexate—lung cancer	1.66e-05	0.000128	CcSEcCtD
Diclofenac—Dry mouth—Doxorubicin—lung cancer	1.65e-05	0.000127	CcSEcCtD
Diclofenac—Vomiting—Docetaxel—lung cancer	1.64e-05	0.000127	CcSEcCtD
Diclofenac—Dyspepsia—Methotrexate—lung cancer	1.64e-05	0.000127	CcSEcCtD
Diclofenac—Rash—Docetaxel—lung cancer	1.63e-05	0.000126	CcSEcCtD
Diclofenac—Dermatitis—Docetaxel—lung cancer	1.63e-05	0.000126	CcSEcCtD
Diclofenac—Confusional state—Doxorubicin—lung cancer	1.63e-05	0.000126	CcSEcCtD
Diclofenac—Decreased appetite—Methotrexate—lung cancer	1.62e-05	0.000125	CcSEcCtD
Diclofenac—Headache—Docetaxel—lung cancer	1.62e-05	0.000125	CcSEcCtD
Diclofenac—Oedema—Doxorubicin—lung cancer	1.61e-05	0.000125	CcSEcCtD
Diclofenac—Anaphylactic shock—Doxorubicin—lung cancer	1.61e-05	0.000125	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Methotrexate—lung cancer	1.61e-05	0.000125	CcSEcCtD
Diclofenac—Fatigue—Methotrexate—lung cancer	1.61e-05	0.000124	CcSEcCtD
Diclofenac—Infection—Doxorubicin—lung cancer	1.6e-05	0.000124	CcSEcCtD
Diclofenac—Pain—Methotrexate—lung cancer	1.59e-05	0.000123	CcSEcCtD
Diclofenac—Shock—Doxorubicin—lung cancer	1.59e-05	0.000123	CcSEcCtD
Diclofenac—Nervous system disorder—Doxorubicin—lung cancer	1.58e-05	0.000122	CcSEcCtD
Diclofenac—Thrombocytopenia—Doxorubicin—lung cancer	1.58e-05	0.000122	CcSEcCtD
Diclofenac—Tachycardia—Doxorubicin—lung cancer	1.57e-05	0.000122	CcSEcCtD
Diclofenac—Skin disorder—Doxorubicin—lung cancer	1.57e-05	0.000121	CcSEcCtD
Diclofenac—Hyperhidrosis—Doxorubicin—lung cancer	1.56e-05	0.000121	CcSEcCtD
Diclofenac—Anorexia—Doxorubicin—lung cancer	1.54e-05	0.000119	CcSEcCtD
Diclofenac—Nausea—Docetaxel—lung cancer	1.54e-05	0.000119	CcSEcCtD
Diclofenac—Feeling abnormal—Methotrexate—lung cancer	1.53e-05	0.000119	CcSEcCtD
Diclofenac—Gastrointestinal pain—Methotrexate—lung cancer	1.52e-05	0.000118	CcSEcCtD
Diclofenac—Hypotension—Doxorubicin—lung cancer	1.51e-05	0.000117	CcSEcCtD
Diclofenac—Urticaria—Methotrexate—lung cancer	1.48e-05	0.000115	CcSEcCtD
Diclofenac—Abdominal pain—Methotrexate—lung cancer	1.47e-05	0.000114	CcSEcCtD
Diclofenac—Body temperature increased—Methotrexate—lung cancer	1.47e-05	0.000114	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Doxorubicin—lung cancer	1.47e-05	0.000114	CcSEcCtD
Diclofenac—Insomnia—Doxorubicin—lung cancer	1.46e-05	0.000113	CcSEcCtD
Diclofenac—Paraesthesia—Doxorubicin—lung cancer	1.45e-05	0.000112	CcSEcCtD
Diclofenac—Dyspnoea—Doxorubicin—lung cancer	1.44e-05	0.000111	CcSEcCtD
Diclofenac—Somnolence—Doxorubicin—lung cancer	1.43e-05	0.000111	CcSEcCtD
Diclofenac—Dyspepsia—Doxorubicin—lung cancer	1.42e-05	0.00011	CcSEcCtD
Diclofenac—Decreased appetite—Doxorubicin—lung cancer	1.4e-05	0.000109	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Doxorubicin—lung cancer	1.39e-05	0.000108	CcSEcCtD
Diclofenac—Fatigue—Doxorubicin—lung cancer	1.39e-05	0.000108	CcSEcCtD
Diclofenac—Pain—Doxorubicin—lung cancer	1.38e-05	0.000107	CcSEcCtD
Diclofenac—Constipation—Doxorubicin—lung cancer	1.38e-05	0.000107	CcSEcCtD
Diclofenac—Hypersensitivity—Methotrexate—lung cancer	1.37e-05	0.000106	CcSEcCtD
Diclofenac—Asthenia—Methotrexate—lung cancer	1.34e-05	0.000103	CcSEcCtD
Diclofenac—Feeling abnormal—Doxorubicin—lung cancer	1.33e-05	0.000103	CcSEcCtD
Diclofenac—Gastrointestinal pain—Doxorubicin—lung cancer	1.32e-05	0.000102	CcSEcCtD
Diclofenac—Pruritus—Methotrexate—lung cancer	1.32e-05	0.000102	CcSEcCtD
Diclofenac—Urticaria—Doxorubicin—lung cancer	1.28e-05	9.92e-05	CcSEcCtD
Diclofenac—Body temperature increased—Doxorubicin—lung cancer	1.28e-05	9.87e-05	CcSEcCtD
Diclofenac—Abdominal pain—Doxorubicin—lung cancer	1.28e-05	9.87e-05	CcSEcCtD
Diclofenac—Diarrhoea—Methotrexate—lung cancer	1.27e-05	9.87e-05	CcSEcCtD
Diclofenac—Dizziness—Methotrexate—lung cancer	1.23e-05	9.54e-05	CcSEcCtD
Diclofenac—Hypersensitivity—Doxorubicin—lung cancer	1.19e-05	9.2e-05	CcSEcCtD
Diclofenac—Vomiting—Methotrexate—lung cancer	1.18e-05	9.17e-05	CcSEcCtD
Diclofenac—Rash—Methotrexate—lung cancer	1.17e-05	9.09e-05	CcSEcCtD
Diclofenac—Dermatitis—Methotrexate—lung cancer	1.17e-05	9.09e-05	CcSEcCtD
Diclofenac—Headache—Methotrexate—lung cancer	1.17e-05	9.04e-05	CcSEcCtD
Diclofenac—Asthenia—Doxorubicin—lung cancer	1.16e-05	8.96e-05	CcSEcCtD
Diclofenac—Pruritus—Doxorubicin—lung cancer	1.14e-05	8.84e-05	CcSEcCtD
Diclofenac—Nausea—Methotrexate—lung cancer	1.11e-05	8.57e-05	CcSEcCtD
Diclofenac—Diarrhoea—Doxorubicin—lung cancer	1.1e-05	8.54e-05	CcSEcCtD
Diclofenac—Dizziness—Doxorubicin—lung cancer	1.07e-05	8.26e-05	CcSEcCtD
Diclofenac—Vomiting—Doxorubicin—lung cancer	1.03e-05	7.94e-05	CcSEcCtD
Diclofenac—Rash—Doxorubicin—lung cancer	1.02e-05	7.87e-05	CcSEcCtD
Diclofenac—Dermatitis—Doxorubicin—lung cancer	1.02e-05	7.87e-05	CcSEcCtD
Diclofenac—Headache—Doxorubicin—lung cancer	1.01e-05	7.82e-05	CcSEcCtD
Diclofenac—Nausea—Doxorubicin—lung cancer	9.58e-06	7.42e-05	CcSEcCtD
Diclofenac—ALB—Metabolism—CYP1A1—lung cancer	1.42e-06	1.48e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—APOA1—lung cancer	1.42e-06	1.48e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ERCC2—lung cancer	1.42e-06	1.47e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.42e-06	1.47e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ALDOA—lung cancer	1.42e-06	1.47e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—EGFR—lung cancer	1.42e-06	1.47e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—ERCC2—lung cancer	1.41e-06	1.47e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PTEN—lung cancer	1.41e-06	1.46e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—KRAS—lung cancer	1.4e-06	1.45e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CAT—lung cancer	1.39e-06	1.45e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ABCB1—lung cancer	1.39e-06	1.44e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MAPK3—lung cancer	1.39e-06	1.44e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP2E1—lung cancer	1.39e-06	1.44e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CG—lung cancer	1.38e-06	1.43e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NCOA3—lung cancer	1.37e-06	1.43e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—NQO1—lung cancer	1.37e-06	1.42e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—TYMS—lung cancer	1.36e-06	1.42e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PTEN—lung cancer	1.36e-06	1.41e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.36e-06	1.41e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MYC—lung cancer	1.35e-06	1.4e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GSTM1—lung cancer	1.35e-06	1.4e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—EP300—lung cancer	1.34e-06	1.4e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.34e-06	1.39e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—APOA1—lung cancer	1.34e-06	1.39e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ABCG2—lung cancer	1.34e-06	1.39e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ADCY1—lung cancer	1.34e-06	1.39e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—KRAS—lung cancer	1.34e-06	1.39e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GSTP1—lung cancer	1.34e-06	1.39e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—TYMS—lung cancer	1.33e-06	1.38e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CB—lung cancer	1.33e-06	1.38e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.33e-06	1.38e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CG—lung cancer	1.32e-06	1.38e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—EGFR—lung cancer	1.32e-06	1.37e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTGS2—lung cancer	1.32e-06	1.37e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GSTM1—lung cancer	1.32e-06	1.37e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—HPGDS—lung cancer	1.31e-06	1.36e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ENO2—lung cancer	1.31e-06	1.36e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—POMC—lung cancer	1.31e-06	1.36e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.3e-06	1.35e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CAT—lung cancer	1.3e-06	1.35e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CG—lung cancer	1.3e-06	1.35e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—EP300—lung cancer	1.3e-06	1.35e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MDM2—lung cancer	1.3e-06	1.35e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.29e-06	1.34e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—RAF1—lung cancer	1.29e-06	1.34e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—PIK3CA—lung cancer	1.28e-06	1.33e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.28e-06	1.33e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CYP1A1—lung cancer	1.28e-06	1.33e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CREBBP—lung cancer	1.28e-06	1.33e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—ERBB2—lung cancer	1.28e-06	1.33e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTT1—lung cancer	1.27e-06	1.32e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ERCC2—lung cancer	1.27e-06	1.32e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ABCB1—lung cancer	1.27e-06	1.31e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CB—lung cancer	1.26e-06	1.31e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MTOR—lung cancer	1.26e-06	1.31e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—POMC—lung cancer	1.26e-06	1.31e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CD4—lung cancer	1.26e-06	1.31e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PIK3CA—lung cancer	1.26e-06	1.31e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GCLC—lung cancer	1.26e-06	1.31e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP2A6—lung cancer	1.26e-06	1.31e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CYP1A1—lung cancer	1.25e-06	1.3e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—KRAS—lung cancer	1.25e-06	1.29e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—TYMS—lung cancer	1.24e-06	1.29e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TP53—lung cancer	1.24e-06	1.29e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ERCC2—lung cancer	1.24e-06	1.28e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—STK11—lung cancer	1.23e-06	1.28e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—POMC—lung cancer	1.23e-06	1.28e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GSTM1—lung cancer	1.23e-06	1.28e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PIK3CA—lung cancer	1.23e-06	1.28e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—APOA1—lung cancer	1.23e-06	1.28e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CREBBP—lung cancer	1.23e-06	1.28e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PIK3CA—lung cancer	1.22e-06	1.27e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CG—lung cancer	1.22e-06	1.27e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—APOA1—lung cancer	1.22e-06	1.27e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CD—lung cancer	1.21e-06	1.26e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CREBBP—lung cancer	1.2e-06	1.25e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—ALB—lung cancer	1.2e-06	1.24e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ENO1—lung cancer	1.19e-06	1.24e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TP53—lung cancer	1.19e-06	1.23e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—HRAS—lung cancer	1.19e-06	1.23e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.18e-06	1.22e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.17e-06	1.21e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CYP1A1—lung cancer	1.16e-06	1.21e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CD—lung cancer	1.16e-06	1.21e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—POMC—lung cancer	1.16e-06	1.21e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.16e-06	1.2e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ERCC2—lung cancer	1.16e-06	1.2e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ALB—lung cancer	1.15e-06	1.19e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTEN—lung cancer	1.15e-06	1.19e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PIK3CA—lung cancer	1.15e-06	1.19e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTP1—lung cancer	1.14e-06	1.19e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CD—lung cancer	1.14e-06	1.18e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—HRAS—lung cancer	1.14e-06	1.18e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CREBBP—lung cancer	1.13e-06	1.18e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ALB—lung cancer	1.13e-06	1.17e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CG—lung cancer	1.12e-06	1.16e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CG—lung cancer	1.11e-06	1.16e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CAT—lung cancer	1.11e-06	1.15e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.11e-06	1.15e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—APOA1—lung cancer	1.1e-06	1.14e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—EP300—lung cancer	1.1e-06	1.14e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CDKN1A—lung cancer	1.09e-06	1.13e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PTEN—lung cancer	1.09e-06	1.13e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IL6—lung cancer	1.09e-06	1.13e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ABCB1—lung cancer	1.08e-06	1.12e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CD—lung cancer	1.07e-06	1.12e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—APOA1—lung cancer	1.07e-06	1.11e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP2E1—lung cancer	1.07e-06	1.11e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—POMC—lung cancer	1.07e-06	1.11e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—TYMS—lung cancer	1.06e-06	1.1e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ALB—lung cancer	1.06e-06	1.1e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—POMC—lung cancer	1.06e-06	1.1e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—HRAS—lung cancer	1.06e-06	1.1e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NQO1—lung cancer	1.06e-06	1.1e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CB—lung cancer	1.06e-06	1.1e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTM1—lung cancer	1.05e-06	1.09e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.05e-06	1.09e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—AKT1—lung cancer	1.05e-06	1.09e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CREBBP—lung cancer	1.04e-06	1.08e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EP300—lung cancer	1.04e-06	1.08e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CREBBP—lung cancer	1.03e-06	1.07e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—AKT1—lung cancer	1.03e-06	1.07e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CB—lung cancer	1.01e-06	1.05e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—IL6—lung cancer	1.01e-06	1.05e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—SRC—lung cancer	1.01e-06	1.05e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTGS2—lung cancer	1.01e-06	1.04e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—AKT1—lung cancer	1e-06	1.04e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CG—lung cancer	1e-06	1.04e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—AKT1—lung cancer	1e-06	1.04e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—APOA1—lung cancer	9.99e-07	1.04e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP1A1—lung cancer	9.95e-07	1.03e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PIK3CA—lung cancer	9.94e-07	1.03e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CB—lung cancer	9.94e-07	1.03e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ERCC2—lung cancer	9.87e-07	1.03e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CD—lung cancer	9.85e-07	1.02e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTGS2—lung cancer	9.85e-07	1.02e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CD—lung cancer	9.8e-07	1.02e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CG—lung cancer	9.77e-07	1.01e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—STAT3—lung cancer	9.74e-07	1.01e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ALB—lung cancer	9.73e-07	1.01e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NRAS—lung cancer	9.72e-07	1.01e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PIK3CA—lung cancer	9.59e-07	9.96e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	9.57e-07	9.94e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—STK11—lung cancer	9.53e-07	9.9e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—POMC—lung cancer	9.52e-07	9.89e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CB—lung cancer	9.37e-07	9.73e-06	CbGpPWpGaD
Diclofenac—ABCC1—Disease—AKT1—lung cancer	9.35e-07	9.72e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MAPK3—lung cancer	9.31e-07	9.67e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—POMC—lung cancer	9.3e-07	9.66e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTGS2—lung cancer	9.28e-07	9.64e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CREBBP—lung cancer	9.28e-07	9.64e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CG—lung cancer	9.12e-07	9.48e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PTEN—lung cancer	9.12e-07	9.47e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CREBBP—lung cancer	9.05e-07	9.4e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MYC—lung cancer	9.05e-07	9.4e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EGFR—lung cancer	8.85e-07	9.2e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTP1—lung cancer	8.82e-07	9.16e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CD—lung cancer	8.8e-07	9.14e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTEN—lung cancer	8.77e-07	9.11e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—EP300—lung cancer	8.7e-07	9.04e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—POMC—lung cancer	8.68e-07	9.02e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ALB—lung cancer	8.68e-07	9.02e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CB—lung cancer	8.59e-07	8.92e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTEN—lung cancer	8.59e-07	8.92e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CD—lung cancer	8.59e-07	8.92e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CAT—lung cancer	8.58e-07	8.91e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CB—lung cancer	8.54e-07	8.87e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—APOA1—lung cancer	8.54e-07	8.87e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTGS2—lung cancer	8.51e-07	8.84e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ALB—lung cancer	8.48e-07	8.8e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTGS2—lung cancer	8.46e-07	8.79e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CREBBP—lung cancer	8.46e-07	8.79e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—KRAS—lung cancer	8.36e-07	8.69e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—EP300—lung cancer	8.36e-07	8.68e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ABCB1—lung cancer	8.35e-07	8.67e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—TYMS—lung cancer	8.2e-07	8.51e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—EP300—lung cancer	8.19e-07	8.51e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.18e-07	8.49e-06	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—AKT1—lung cancer	8.12e-07	8.44e-06	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CA—lung cancer	8.11e-07	8.42e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTM1—lung cancer	8.1e-07	8.42e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTEN—lung cancer	8.1e-07	8.41e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CD—lung cancer	8.02e-07	8.33e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ALB—lung cancer	7.92e-07	8.22e-06	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—AKT1—lung cancer	7.83e-07	8.14e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CG—lung cancer	7.8e-07	8.1e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—EP300—lung cancer	7.72e-07	8.02e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CA—lung cancer	7.68e-07	7.98e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP1A1—lung cancer	7.68e-07	7.98e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CB—lung cancer	7.67e-07	7.96e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ERCC2—lung cancer	7.62e-07	7.91e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTGS2—lung cancer	7.6e-07	7.89e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CB—lung cancer	7.48e-07	7.77e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTEN—lung cancer	7.42e-07	7.71e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—POMC—lung cancer	7.42e-07	7.71e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTGS2—lung cancer	7.41e-07	7.7e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTEN—lung cancer	7.38e-07	7.67e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CREBBP—lung cancer	7.23e-07	7.51e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—HRAS—lung cancer	7.11e-07	7.38e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—EP300—lung cancer	7.08e-07	7.35e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—EP300—lung cancer	7.04e-07	7.31e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CB—lung cancer	6.99e-07	7.26e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTGS2—lung cancer	6.93e-07	7.19e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CD—lung cancer	6.85e-07	7.12e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—IL6—lung cancer	6.8e-07	7.07e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ALB—lung cancer	6.77e-07	7.03e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTEN—lung cancer	6.63e-07	6.88e-06	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—AKT1—lung cancer	6.62e-07	6.88e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—APOA1—lung cancer	6.59e-07	6.85e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTEN—lung cancer	6.47e-07	6.72e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CA—lung cancer	6.44e-07	6.68e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—EP300—lung cancer	6.32e-07	6.56e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—AKT1—lung cancer	6.28e-07	6.52e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CA—lung cancer	6.19e-07	6.42e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—EP300—lung cancer	6.17e-07	6.41e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CA—lung cancer	6.06e-07	6.29e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTEN—lung cancer	6.04e-07	6.27e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CG—lung cancer	6.02e-07	6.25e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CB—lung cancer	5.97e-07	6.2e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTGS2—lung cancer	5.92e-07	6.15e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—EP300—lung cancer	5.76e-07	5.98e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—POMC—lung cancer	5.73e-07	5.95e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CA—lung cancer	5.71e-07	5.93e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CREBBP—lung cancer	5.58e-07	5.79e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CD—lung cancer	5.29e-07	5.49e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—AKT1—lung cancer	5.26e-07	5.46e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CA—lung cancer	5.24e-07	5.44e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ALB—lung cancer	5.22e-07	5.42e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CA—lung cancer	5.21e-07	5.41e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTEN—lung cancer	5.16e-07	5.36e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—AKT1—lung cancer	5.05e-07	5.25e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—AKT1—lung cancer	4.95e-07	5.14e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—EP300—lung cancer	4.92e-07	5.11e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CA—lung cancer	4.67e-07	4.85e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—AKT1—lung cancer	4.67e-07	4.85e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CB—lung cancer	4.61e-07	4.79e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTGS2—lung cancer	4.57e-07	4.74e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CA—lung cancer	4.56e-07	4.74e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—AKT1—lung cancer	4.28e-07	4.44e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CA—lung cancer	4.26e-07	4.43e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—AKT1—lung cancer	4.25e-07	4.42e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTEN—lung cancer	3.98e-07	4.14e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—AKT1—lung cancer	3.82e-07	3.97e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—EP300—lung cancer	3.8e-07	3.95e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—AKT1—lung cancer	3.73e-07	3.87e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CA—lung cancer	3.64e-07	3.78e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—AKT1—lung cancer	3.48e-07	3.62e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AKT1—lung cancer	2.98e-07	3.09e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CA—lung cancer	2.81e-07	2.92e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AKT1—lung cancer	2.3e-07	2.38e-06	CbGpPWpGaD
